ArticleCase reports in rheumatology2026

Dose-Escalated Upadacitinib for Refractory Myositis in Anti-Jo-1-Positive Antisynthetase Syndrome: A Case Report.

Yuji Kukida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.